Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Gene patents may hamper innovations in patient care

No earlier versions found for this Subject.

Return to Gene patents may hamper innovations in patient care

Gene patents are discoveries, not inventions and patenting discoveries may hamper future innovations in developing cost-effective patient care products and services. Banning gene patents may offer incredible opportunities for innovations that can attract investments to create sustainable entrepreneurial establishments and scientific jobs, which may be significantly higher that gene patents alone can offer. In contrast, granting gene patents may lead to innovation bottlenecks that favor fewer inventions, restricted entrepreneurial initiatives, limited job growth, and non-competitive monopoly. Read the full blog: sciclips.com